[S-07] Extending the clinical spectrum of cerebral amyloid angiopathy (CAA)

[S-07-1] 脳アミロイドアンギオパチー関連脳血管障害の臨床スペクトル

薬師寺 祐介, 原 英夫 (佐賀大学医学部　内科学講座 神経内科)

Cerebral amyloid angiopathy (CAA) , a common finding in the aging brain, is caused by accumulation of amyloid beta protein in the cerebral vasculature. Recent studies have revealed that CAA has a wider clinical spectrum than previously recognized. CAA should be in differential diagnosis of patients with lobar intracerebral hemorrhage, cognitive impairment, transient neurological symptoms, headache, and other neurological manifestations. Understanding of the growing clinical spectrum of CAA would lead to a more appropriate approach towards management of patients with CAA-related neurological disorders. In this symposium, experts in this field discuss (1) the wide clinical spectrum of CAA-related cerebrovascular disorders, (2) CAA-related cognitive impairment and inflammation, and (3) management of CAA, including current clinical implications and future perspectives for therapies against CAA.

・Job title: Lecture for Division of Neurology, Department of Internal Medicine
・Affiliation: Saga University Faculty of Medicine, Japan
・Education: 2008 Ph.D. (Doctor of Medical Science), Graduate School of Medical Science,
Saga University Faculty of Medicine
1996 M.D., cum laude, Saga Medical School
・Study Abroad: 2012-2014, Visiting Research Associate, Stroke research center (Prof. David J Werring), Department of Brain Repair and Rehabilitation, UCL Institute of Neurology.
・Certifications
2011　The board of the Japan Society for Dementia research
2006 The board of the Japan Stroke Society
2002 The board of the Japanese Society of Neurology
2001 The board of the Japanese Society of Internal Medicine
・Award: 2012 Award for the 21st Annual meeting of Japanese Brain Dock Society.
・Research Interests: Cerebral small vessel disease, brain hemorrhage, Neurocognitive disorders